The use of donor T cells offers several benefits, including the potential to overcome immune evasion mechanisms employed by cancer cells. Donor T cells can also provide a more robust immune response compared to the patient's own T cells, especially if the patient's immune system is weakened by prior treatments. Additionally, donor T cells can be engineered to enhance their specificity and efficacy against cancer cells.
